| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69bddb4c84704857f70d926c31a6e1a2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-37288
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3627
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3621
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-37235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-37282 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-39624
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36139
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36114
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36117
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36057 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36 |
| filingDate |
2012-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a136faefbcbb8d68f669b5e0e1a1a0eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d2471046ad1e289ebbcb77269b2e773
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4116c8203ca176f23929ef8d72d644ff |
| publicationDate |
2013-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2013082022-A1 |
| titleOfInvention |
Autonomic modulation using peripheral nerve field stimulation |
| abstract |
Some embodiments provide a system, comprising a peripheral nerve field modulation (PNFM) therapy delivery system, PNFM electrodes configured to be implanted subcutaneously, and a controller. The PNFM electrodes are electrically connected to the PNFM therapy system. The PNFM therapy delivery system and the PNFM electrodes are configured to deliver current and/or control the field potentials at one or more peripheral nerve fields. The controller is configured to control the PNFM therapy delivery system to deliver a PNFM therapy to the one or more peripheral nerve fields. The controller includes a scheduler configured to control timing of the PNFM therapy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8880170-B2 |
| priorityDate |
2011-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |